• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Susan Urba, MD, Addresses Risks Associated with Untreated Chemotherapy-Induced Nausea and Vomiting

Article

"There is a substantial number of risks associated with chemotherapy-induced nausea and vomiting (CINV)," said Susan Urba, MD, Medical Director, Symptom Management & Supportive Care Program, University of Michigan.

"There is a substantial number of risks associated with chemotherapy-induced nausea and vomiting (CINV)," said Susan Urba, MD, Medical Director, Symptom Management & Supportive Care Program, University of Michigan. The patient's quality-of-life is the main risk and concern of untreated CINV. Dr Urba also discusses the cost issues associated with uncontrolled CINV. Patient education is crucial in the prevention of unnecessary costs from extra office visits or hospitalization.

Related Videos
Refat Rasul Srejon, MPH
Screenshot of an interview with Nicolas Girard, MD, PhD
Byoung Chul Cho, MD, PhD
Beth Stein, MD, and Ratna Kiran Bhavaraju-Sanka, MD
Efren Flores, MD
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.